169 related articles for article (PubMed ID: 38650932)
41. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
[TBL] [Abstract][Full Text] [Related]
42. An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function.
Oh H; Grinberg-Bleyer Y; Liao W; Maloney D; Wang P; Wu Z; Wang J; Bhatt DM; Heise N; Schmid RM; Hayden MS; Klein U; Rabadan R; Ghosh S
Immunity; 2017 Sep; 47(3):450-465.e5. PubMed ID: 28889947
[TBL] [Abstract][Full Text] [Related]
43. Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans.
Pomerantz JL; Milner JD; Snow AL
Curr Opin Immunol; 2022 Dec; 79():102255. PubMed ID: 36334349
[TBL] [Abstract][Full Text] [Related]
44. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.
Wu C; de Miranda NF; Chen L; Wasik AM; Mansouri L; Jurczak W; Galazka K; Dlugosz-Danecka M; Machaczka M; Zhang H; Peng R; Morin RD; Rosenquist R; Sander B; Pan-Hammarström Q
Oncotarget; 2016 Jun; 7(25):38180-38190. PubMed ID: 27224912
[TBL] [Abstract][Full Text] [Related]
45. Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency.
Fuchs S; Rensing-Ehl A; Pannicke U; Lorenz MR; Fisch P; Jeelall Y; Rohr J; Speckmann C; Vraetz T; Farmand S; Schmitt-Graeff A; Krüger M; Strahm B; Henneke P; Enders A; Horikawa K; Goodnow C; Schwarz K; Ehl S
Blood; 2015 Oct; 126(14):1658-69. PubMed ID: 26289640
[TBL] [Abstract][Full Text] [Related]
46. Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway.
Smith CIE; Burger JA
Front Immunol; 2021; 12():689472. PubMed ID: 34177947
[TBL] [Abstract][Full Text] [Related]
47. A familial case of B-cell expansion with NF-κB and T-cell anergy caused by a G123D heterozygous missense mutation in the CARD11 gene.
Takase Y; Tanioka S; Ishimura M; Yoshiura KI; Mori Y; Sakaida E; Funakoshi Y; Moriuchi H
Pediatr Blood Cancer; 2022 Dec; 69(12):e29941. PubMed ID: 36129242
[TBL] [Abstract][Full Text] [Related]
48. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11).
Dadi H; Jones TA; Merico D; Sharfe N; Ovadia A; Schejter Y; Reid B; Sun M; Vong L; Atkinson A; Lavi S; Pomerantz JL; Roifman CM
J Allergy Clin Immunol; 2018 May; 141(5):1818-1830.e2. PubMed ID: 28826773
[TBL] [Abstract][Full Text] [Related]
49. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
[TBL] [Abstract][Full Text] [Related]
50. Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India.
Gupta M; Aluri J; Desai M; Lokeshwar M; Taur P; Lenardo M; Bergerson J; Dalvi A; Mhatre S; Kulkarni M; Kambli P; Madkaikar M
Front Immunol; 2018; 9():1049. PubMed ID: 29963038
[TBL] [Abstract][Full Text] [Related]
51. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B.
Bertin J; Wang L; Guo Y; Jacobson MD; Poyet JL; Srinivasula SM; Merriam S; DiStefano PS; Alnemri ES
J Biol Chem; 2001 Apr; 276(15):11877-82. PubMed ID: 11278692
[TBL] [Abstract][Full Text] [Related]
52. SHARPIN controls the development of regulatory T cells.
Redecke V; Chaturvedi V; Kuriakose J; Häcker H
Immunology; 2016 Jun; 148(2):216-26. PubMed ID: 26931177
[TBL] [Abstract][Full Text] [Related]
53. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
54. Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.
Cheng J; Hamilton KS; Kane LP
Mol Immunol; 2014 May; 59(1):110-6. PubMed ID: 24548923
[TBL] [Abstract][Full Text] [Related]
55. BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation.
Seeholzer T; Kurz S; Schlauderer F; Woods S; Gehring T; Widmann S; Lammens K; Krappmann D
Front Immunol; 2018; 9():2695. PubMed ID: 30515170
[TBL] [Abstract][Full Text] [Related]
56. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract][Full Text] [Related]
57. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells.
Molinero LL; Yang J; Gajewski T; Abraham C; Farrar MA; Alegre ML
J Immunol; 2009 Jun; 182(11):6736-43. PubMed ID: 19454668
[TBL] [Abstract][Full Text] [Related]
58.
Hutcherson SM; Bedsaul JR; Pomerantz JL
J Immunol; 2021 Aug; 207(4):1150-1164. PubMed ID: 34341167
[TBL] [Abstract][Full Text] [Related]
59. Central immune tolerance depends on crosstalk between the classical and alternative NF-κB pathways in medullary thymic epithelial cells.
Riemann M; Andreas N; Fedoseeva M; Meier E; Weih D; Freytag H; Schmidt-Ullrich R; Klein U; Wang ZQ; Weih F
J Autoimmun; 2017 Jul; 81():56-67. PubMed ID: 28385374
[TBL] [Abstract][Full Text] [Related]
60. Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells.
Kutzner K; Woods S; Karayel O; Gehring T; Yin H; Flatley A; Graß C; Wimberger N; Tofaute MJ; Seeholzer T; Feederle R; Mann M; Krappmann D
Sci Signal; 2022 Mar; 15(723):eabk3083. PubMed ID: 35230873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
